These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2669768)

  • 41. Diagnosis of Lyme disease.
    Lancet; 1989 Jul; 2(8656):198-9. PubMed ID: 2568526
    [No Abstract]   [Full Text] [Related]  

  • 42. Diagnosis of Lyme disease should be made on clinical grounds.
    Berman DS; Wenglin BD
    J Infect Dis; 1993 Oct; 168(4):1073. PubMed ID: 8376824
    [No Abstract]   [Full Text] [Related]  

  • 43. [Actual diagnostic possibilities of Lyme borreliosis].
    Hermanowska-Szpakowicz T; Swierzbińska R; Zajkowska JM; Izycka-Herman A; Pancewicz SA; Kondrusik M
    Pol Merkur Lekarski; 2000 Jan; 7(43):69-71. PubMed ID: 10765660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Laboratory diagnosis of infection caused by Borrelia burgdorferi].
    Dessau RB; Bangsborg JM; Jensen TP; Hansen K; Lebech AM; Andersen CØ
    Ugeskr Laeger; 2006 Aug; 168(34):2805-7. PubMed ID: 16942701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical comparison of borreliacidal-antibody test with indirect immunofluorescence and enzyme-linked immunosorbent assays for diagnosis of Lyme disease.
    Agger WA; Case KL
    Mayo Clin Proc; 1997 Jun; 72(6):510-4. PubMed ID: 9179134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lyme disease acquired in Israel: report of a case and studies of serological cross reactivity in relapsing fever.
    Berger SA; Samish M; Kletter Y; Tinghitella T; Heering S; Edberg SC
    Isr J Med Sci; 1993 Aug; 29(8):464-5. PubMed ID: 8407274
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of Peptide library screening to detect a previously unknown linear diagnostic epitope: proof of principle by use of lyme disease sera.
    Hamby CV; Llibre M; Utpat S; Wormser GP
    Clin Diagn Lab Immunol; 2005 Jul; 12(7):801-7. PubMed ID: 16002626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibody testing in Lyme disease. A comparison of results in four laboratories.
    Schwartz BS; Goldstein MD; Ribeiro JM; Schulze TL; Shahied SI
    JAMA; 1989 Dec 22-29; 262(24):3431-4. PubMed ID: 2685383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness of peptide-antigen immunoassays for Lyme disease.
    Porwancher RB
    J Infect Dis; 2004 May; 189(10):1962; author reply 1962-4. PubMed ID: 15122535
    [No Abstract]   [Full Text] [Related]  

  • 50. [Preparations for serodiagnosis of diseases due to causative agents of ixode tick-borne Borreliosis (Lyme disease). Communication 2. Comparative study of recombinant enzyme immunoassay test-systems (rELISA) for serological diagnosis of ixode tick-borne Borreliosis].
    Manzeniuk IN; Vorob'eva MS; Nikitiuk NM; Arumova EA; Anan'eva LP; Baranova SG; Viatkina TG; Masiago AV; Kozarenko AA; Andreĭchuk IuA
    Antibiot Khimioter; 2004; 49(8-9):25-8. PubMed ID: 15727142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Significance of specific antibody determination in Lyme borreliosis diagnosis.
    Bazovska S; Kondas M; Simkovicova M; Kmety E; Traubner P
    Bratisl Lek Listy; 2001; 102(10):454-7. PubMed ID: 11802291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Value of clinical symptoms, intrathecal specific antibody production and PCR in CSF in the diagnosis of childhood Lyme neuroborreliosis.
    Issakainen J; Gnehm HE; Lucchini GM; Zbinden R
    Klin Padiatr; 1996; 208(3):106-9. PubMed ID: 8676596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enzyme-linked immunosorbent assay for detection of Shiga toxin-producing Escherichia coli infection by antibodies to Escherichia coli secreted protein B in children with hemolytic uremic syndrome.
    Sjögren AC; Kaper JB; Caprioli A; Karpman D
    Eur J Clin Microbiol Infect Dis; 2004 Mar; 23(3):208-11. PubMed ID: 14986162
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of anti-FloR antibody on florfenicol accumulation in florfenicol-resistant Escherichia coli and enzyme-linked immunosorbent assay for detection of florfenicol-resistant E. coli isolates.
    Wu B; Xia C; Du X; Cao X; Shen J
    J Clin Microbiol; 2006 Feb; 44(2):378-82. PubMed ID: 16455887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differentiation between early and late complicated Lyme borreliosis by specific IgG avidity.
    Guérineau AL; Dhôte R; Christiann F; Rayet P; Assous MV
    Lancet; 1999 Sep; 354(9184):1096-7. PubMed ID: 10509507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serologic testing for Lyme disease.
    Schriefer ME; Dennis DT; Gubler DJ; Hayes EB; Johnson BJ; Chu MC
    JAMA; 2000 Aug; 284(6):695-6. PubMed ID: 10927774
    [No Abstract]   [Full Text] [Related]  

  • 57. Simultaneous use of serum IgG and IgM for risk scoring of suspected early Lyme borreliosis: graphical and bivariate analyses.
    Dessau RB; Ejlertsen T; Hilden J
    APMIS; 2010 Apr; 118(4):313-23. PubMed ID: 20402677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of surface immunofluorescence assay (SIFA) in the microbiological diagnosis of Lyme borreliosis: a case report.
    Sambri V; Armati S; D'Apote L; Farencena A; Marangoni A; Massaria F; Moroni A; Cevenini R
    New Microbiol; 1995 Jul; 18(3):307-10. PubMed ID: 7553367
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Study of cross reactions using serological techniques between Borrelia burgdorferi and Treponema pallidum].
    Artero JM; Mellado M; Martín Luengo F
    Enferm Infecc Microbiol Clin; 1991 Feb; 9(2):127-8. PubMed ID: 1854844
    [No Abstract]   [Full Text] [Related]  

  • 60. Sarcoidosis and ELISA for Borrelia burgdorferi.
    Morris JT; Longfield RN
    South Med J; 1994 Jun; 87(6):590-1. PubMed ID: 8202765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.